Endovascular Today

CE Mark Granted for Sequent Medical’s Web SL Family of Neurovascular Aneurysm Embolization Devices

May 20, 2013—Sequent Medical, Inc. (Aliso Viejo, CA) announced that it has received CE Mark approval for the SL (single-layer) family of Web aneurysm embolization devices and has commenced a controlled release of these new models in select neurovascular centers in Europe. The SL family offers a lower profile and excellent navigability that will enable physicians to treat a broader range of aneurysms with the Web platform, the company stated.

Reverse Medical Receives CE Mark Approval for MVP Micro Vascular Plug

May 14, 2013—Reverse Medical Corporation (Irvine, CA) announced that the company’s MVP microvascular plug system for peripheral artery embolization has been granted CE Mark approval to obstruct or reduce the rate of blood flow in the peripheral vasculature.

St. Jude Medical Begins EnligHTN III Study for Next-Generation Renal Denervation System

May 14, 2013—St. Jude Medical, Inc. (St. Paul, MN) announced the commencement of enrollment in the EnligHTN III trial that will evaluate the safety and performance of the company’s second-generation EnligHTN renal denervation system in patients with drug-resistant, uncontrolled hypertension.

CREST Substudy Finds Balloon Angioplasty After Carotid Stenting Reduces Restenosis Risk

May 9, 2013—The Society for Cardiovascular Angiography and Interventions (SCAI) announced the presentation of a CREST (Carotid Revascularization Endarterectomy versus Stenting Trial) substudy at the SCAI 2013 scientific sessions in Orlando, Florida. The objective of this substudy was to evaluate whether undergoing angioplasty after carotid stenting increases the risk of complications such as stroke.

News